Home/Filings/4/0001209191-22-007213
4//SEC Filing

Hackett Joanne M. 4

Accession 0001209191-22-007213

CIK 0001708599other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:50 PM ET

Size

5.5 KB

Accession

0001209191-22-007213

Insider Transaction Report

Form 4
Period: 2022-02-02
Transactions
  • Award

    Option to Purchase Common Stock

    2022-02-02+65,00065,000 total
    Exercise: $0.83Exp: 2032-02-01Common Stock (65,000 underlying)
Footnotes (1)
  • [F1]Options will vest and become exercisable in four equal quarterly installments on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, provided that the grantee remains a director on the last day of the applicable calendar quarter.

Issuer

AgeX Therapeutics, Inc.

CIK 0001708599

Entity typeother

Related Parties

1
  • filerCIK 0001905966

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:50 PM ET
Size
5.5 KB